Andrea Semplicini
Via S. Mattia 20
Padova, 35121, Italy
Padova, 35121, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Mild Hyperuricemia: To Treat, or Not to Treat, That is the Question. Suggestions form the URRAH Study.
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: March 15, 2020
Should We Increase Trust in Cardiovascular Prevention?
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: May 26, 2019
Searching cerebrovascular risk indicators for hypertensive patients: Is Framingham Stroke Risk Profile "the magic bullet"?
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: January 23, 2018
Aortic stenting in the growing sheep causes aortic endothelial dysfunction but not hypertension: Clinical implications for coarctation repair.
Journal: Congenital heart disease
Published: May 18, 2016
Cerebral White Matter Lesions as a Clinically Relevant Intermediate Target of Cerebrovascular Prevention.
Journal: Journal of clinical hypertension (Greenwich, Conn.)
Published: June 03, 2015
G-Protein β3-Subunit Gene C825T Polymorphism and Cardiovascular Risk: An Updated Review.
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: February 28, 2015
An update on hypertensive emergencies and urgencies.
Journal: Journal of cardiovascular medicine (Hagerstown, Md.)
Published: January 10, 2015
NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.
Journal: Vascular pharmacology
Published: December 16, 2014
Sirtuin 1 stabilization by HuR represses TNF-α- and glucose-induced E-selectin release and endothelial cell adhesiveness in vitro: relevance to human metabolic syndrome.
Journal: Clinical science (London, England : 1979)
Published: April 08, 2014
Thirty and ninety days mortality predictive value of admission and in-hospital procalcitonin and mid-regional pro-adrenomedullin testing in patients with dyspnea. Results from the VERyfing DYspnea trial.
Journal: The American journal of emergency medicine
Published: July 22, 2013
Last Updated: 09/26/2026